HOUSTON, March 1, 2011 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq:SMED) ("Sharps" or the "Company"), a leading full-service provider of cost-effective management solutions for medical waste and unused medications generated outside the hospital and large healthcare facility setting, announced today that David P. Tusa, Chief Executive Officer and President, and Diana P. Diaz, Vice President and Chief Financial Officer, will participate in two investor conferences in March.

They will first present at the Credit Suisse 13 th Annual Global Services Conference at the Phoenician in Scottsdale, AZ, on Monday, March 14, 2011, at 8:30 a.m. MT / 10:30 a.m. ET.

Management will also present at the Roth Capital Partners' 23 rd Annual OC (Orange County) Growth Stock Conference at the Ritz-Carlton, in Laguna Niguel, CA, on Wednesday, March 16, 2011, at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast of this presentation, along with presentation materials, will be available on the Company's website at www.sharpsinc.com . If you are unable to listen to the live presentation, an archive will be made available, with transcript, on the website in the Investor Relations section. 

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps is a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting.  Its strategy is to capture a large part of the estimated $2 billion untapped market for unused medications, used syringes and medical waste generated outside of hospital and large healthcare settings by targeting the major agencies that are interrelated with this medical waste stream; that is the U.S. government, pharmaceutical manufacturers, home healthcare providers, retail pharmacies and clinics, and the professional market comprised of physicians, dentists and veterinary practices. As a fully integrated medical waste management company providing customer solutions and services, the Company's solid business model, which provides strong margins and significant operating leverage, combined with its early penetration into emerging markets, uniquely positions it for strong future growth.

If you liked this article you might like

TheStreet's Quant Ratings Upgrades Sharps Compliance (SMED) to 'Buy'

Sharps Compliance Is Showing an Interesting Uptrend

Sharps Compliance Is Showing an Interesting Uptrend

Insider Trading Alert - IPXL, TRC And SMED Traded By Insiders

Insider Trading Alert - SRI, SMED And CNX Traded By Insiders

3 Materials & Construction Stocks Driving The Industry Higher